Exicure (XCUR) Non-Current Assets (2016 - 2026)
Exicure (XCUR) reported Non-Current Assets of $9.2 million for Q1 2026, down 1.62% on a YoY basis from $9.4 million in Q1 2025, and down 2.06% quarter-over-quarter from $9.4 million in Q4 2025.
Exicure (XCUR) Non-Current Assets (2016 - 2026) Analysis & Trends
Exicure has reported Non-Current Assets for 11 years, with the latest figure at $9.2 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets fell 1.62% year-over-year to $9.2 million; the trailing twelve-month figure through Mar 2026 stood at $38.6 million (up 40.74% YoY), and the FY2025 full-year result was $9.4 million, up 580.91% from the prior year.
- Non-Current Assets for Q1 2026 stood at $9.2 million, down from $9.4 million in the prior quarter.
- The five-year high for Non-Current Assets was $13.9 million in Q2 2023, with the low at $1.4 million in Q4 2024.
- Historically, Non-Current Assets has averaged $10.1 million across 5 years, with a median of $9.8 million in 2025.
- Annual changes were most pronounced in 2024 — Non-Current Assets sank 85.53% — and 2025, when it jumped 580.91%.
- Exicure's Non-Current Assets stood at $13.3 million in 2022, then declined by 28.03% to $9.6 million in 2023, then slumped by 85.53% to $1.4 million in 2024, then jumped by 580.91% to $9.4 million in 2025, then retreated by 2.06% to $9.2 million in 2026.
- The last three Non-Current Assets figures came in at $9.2 million (Q1 2026), $9.4 million (Q4 2025), and $9.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 62,953.78 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 39.71 Mn |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | 9.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.22 Mn |
| Dec 31, 2025 | 9.42 Mn |
| Sep 30, 2025 | 9.83 Mn |
| Jun 30, 2025 | 10.09 Mn |
| Mar 31, 2025 | 9.38 Mn |
| Dec 31, 2024 | 1.38 Mn |
| Sep 30, 2024 | 8.03 Mn |
| Jun 30, 2024 | 8.61 Mn |
| Mar 31, 2024 | 9.25 Mn |
| Dec 31, 2023 | 9.56 Mn |
| Sep 30, 2023 | 9.86 Mn |
| Jun 30, 2023 | 13.89 Mn |
| Mar 31, 2023 | 12.67 Mn |
| Dec 31, 2022 | 13.28 Mn |
| Sep 30, 2022 | 11.74 Mn |
| Jun 30, 2022 | 12.23 Mn |
| Mar 31, 2022 | 12.71 Mn |
| Dec 31, 2021 | 21.20 Mn |
| Sep 30, 2021 | 13.75 Mn |
| Jun 30, 2021 | 13.82 Mn |